Puma Biotechnology (PBYI) Capital Expenditures Growth (1y) (2012 - 2025)
Puma Biotechnology (PBYI) Capital Expenditures Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Puma Biotechnology | 409.56 Mn | 371.27 Mn | 34.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -200.00% |
| Sep 30, 2025 | 870.00% |
| Jun 30, 2025 | -610.00% |
| Dec 31, 2024 | 38.46% |
| Sep 30, 2024 | 166.67% |
| Dec 31, 2018 | -46.72% |
| Sep 30, 2018 | 98.05% |
| Jun 30, 2018 | 2,462.50% |
| Mar 31, 2018 | -67.74% |
| Dec 31, 2017 | -120.08% |
| Jun 30, 2017 | -99.73% |
| Mar 31, 2017 | 181.82% |
| Dec 31, 2016 | 2,086.44% |
| Jun 30, 2016 | 1,253.52% |
| Mar 31, 2016 | -89.89% |
| Dec 31, 2015 | -28.05% |
| Jun 30, 2015 | -341.51% |
| Mar 31, 2015 | 10,775.00% |
| Dec 31, 2014 | -56.61% |
| Jun 30, 2014 | 159.22% |